Physician profile
David Yoo
NPI 1538523618
$22,743.29
in general payments reported to CMS, 2019-2025
19 companies · $1,968 in 2025
The $1,968 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $131 · 2021: $265 · 2022: $13K · 2023: $5,583 · 2024: $1,700 · 2025: $1,968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,083 · Food and Beverage: $2,367 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,083.35 |
| Food and Beverage | $2,367.15 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,743.46 | 2022-2025 | Affera Mapping System, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $7,226.71 | 2021-2025 | Gallant, Aveir |
| Boston Scientific Corporation | $5,692.15 | 2019-2025 | Emblem Mri S-Icd, Farapulse, General - Ep |
| Pfizer INC. | $368.30 | 2019-2022 | |
| Edwards Lifesciences Corporation | $217.50 | 2025 | Evoque |
| Merck Sharp & Dohme LLC | $75.75 | 2024-2025 | Verquvo |
| Biotronik INC. | $67.27 | 2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Astrazeneca Pharmaceuticals LP | $62.38 | 2020-2025 | Wainua, Farxiga |
| Harrow Eye, LLC | $50.95 | 2025 | Vevye |
| Irhythm Technologies, INC. | $42.93 | 2022 | |
| Alnylam Pharmaceuticals INC. | $26.39 | 2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.44 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.08 | 2024 | Jardiance |
| Cardiva Medical, INC. | $24.72 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Regeneron Healthcare Solutions, INC. | $21.84 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $20.04 | 2025 | Sotalol Hydrochloride |
| Otsuka America Pharmaceutical, INC. | $18.00 | 2019 | |
| Amgen INC. | $17.93 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $16.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.